First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference30 articles.
1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012;Ferlay;Int J Cancer,2015
2. Cancer incidence in Egypt: results of the national population-based cancer registry program;Ibrahim;J Cancer Epidemiol,2014
3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2005
4. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis;El Saghir;Int J Surg,2007
5. Endocrine therapy for hormone receptor-positive metastatic breast cancer: american society of clinical oncology guideline;Rugo;J Clin Oncol,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing;Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery;2023-06-07
2. Combination of microtubule targeting agents with other antineoplastics for cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-09
3. Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review;Frontiers in Pharmacology;2021-12-06
4. The prognostic and predictive significance of cytokeratin 5/6 and epidermal growth factor receptor in metastatic triple-negative breast cancer treated with maintenance capecitabine;Translational Cancer Research;2021-03
5. Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era;International Journal of Molecular Sciences;2020-10-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3